After gaining 64% from IPO issue price, this hospital stock can rally another 18%: Kotak Institutional
The discount to KIMS has been assigned in comparison to the aforementioned peers on the back of high concentration risk with around 2/3rd of the companys sales being accounted for by Hyderabad and higher execution risks given the investment phase lined up over the next few years.